跳转至内容
Merck
CN
  • Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer.

Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer.

PloS one (2014-06-10)
Hoon Hur, Man Jeong Paik, Yi Xuan, Duc-Toan Nguyen, In-Hye Ham, Jisoo Yun, Yong Kwan Cho, Gwang Lee, Sang-Uk Han
摘要

The levels of organic acids representing metabolic pathway end products are important indicators of physiological status, and may be associated with metabolic changes in cancer. The aim of this study is to investigate the levels of organic acids in cancerous and normal tissues from gastric cancer patients and to confirm the role of metabolic alterations in gastric carcinogenesis. Organic acids in normal and cancerous tissues from forty-five patients with gastric adenocarcinoma were investigated by gas chromatography-mass spectrometry in selected ion monitoring mode as methoxime/tert-butyldimethylsilyl derivatives. We analysed the significant differences in the levels of organic acids in normal and cancer tissues and investigated the correlation of these levels in cancer tissues with clinicopathological features. The levels of Krebs cycle components, including α-ketoglutaric acid, succinic acid, fumaric acid, malic acid and oxaloacetic acid, were significantly increased in cancer tissues compared to normal tissues. In addition, the levels of glycolytic products, including pyruvic acid and lactic acid, as well as the levels of ketone bodies, including 3-hydroxybutyric acid, were also significantly increased in cancer tissues compared to normal tissues. The levels of ketone bodies in cancer tissues with differentiated histology and in intestinal-type cancer tissues were significantly increased. The organic acid profiling analysis described here may be a generally useful clinical tool for understanding the complexity of metabolic events in gastric adenocarcinoma, and organic acids may have potential as metabolic markers for the future discovery of diagnostic and therapeutic modalities.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
二氯甲烷, suitable for HPLC, ≥99.8%, contains amylene as stabilizer
Sigma-Aldrich
乙酸乙酯, ACS reagent, ≥99.5%
Sigma-Aldrich
乙酸乙酯, suitable for HPLC, ≥99.7%
Sigma-Aldrich
二氯甲烷, contains 40-150 ppm amylene as stabilizer, ACS reagent, ≥99.5%
Sigma-Aldrich
甲苯, ACS reagent, ≥99.5%
Sigma-Aldrich
二氯甲烷, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%, contains 50-150 ppm amylene as stabilizer
Sigma-Aldrich
甲苯, suitable for HPLC, 99.9%
Sigma-Aldrich
乙酸乙酯, HPLC Plus, for HPLC, GC, and residue analysis, 99.9%
Sigma-Aldrich
甲苯, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%
Sigma-Aldrich
二氯甲烷, anhydrous, ≥99.8%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
甲苯, anhydrous, 99.8%
Sigma-Aldrich
无水柠檬酸粉末, meets analytical specification of Ph. Eur., BP, USP, E330, anhydrous, 99.5-100.5% (based on anhydrous substance)
Sigma-Aldrich
无水柠檬酸粉末, ACS reagent, ≥99.5%
Sigma-Aldrich
二氯甲烷, puriss. p.a., ACS reagent, reag. ISO, ≥99.9% (GC)
Sigma-Aldrich
二氯甲烷, ACS reagent, ≥99.5%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
丁基二甲基氯硅烷, reagent grade, 97%
Sigma-Aldrich
乙酸乙酯, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
乙酸乙酯, suitable for HPLC, ≥99.8%
Sigma-Aldrich
乙酸乙酯, anhydrous, 99.8%
Sigma-Aldrich
无水柠檬酸粉末, ≥99.5%, FCC, FG
Sigma-Aldrich
无水柠檬酸粉末, 99%
Sigma-Aldrich
丙酮酸, 98%
Sigma-Aldrich
乳酸, meets USP testing specifications
Sigma-Aldrich
无水柠檬酸粉末, anhydrous, suitable for cell culture, suitable for plant cell culture
Sigma-Aldrich
甲氧胺 盐酸盐, 98%
Sigma-Aldrich
乳酸, 88%, FCC
Sigma-Aldrich
DL-苹果酸, ReagentPlus®, ≥99%
Sigma-Aldrich
草酰乙酸, ≥97% (HPLC)
Sigma-Aldrich
富马酸, ≥99.0% (T)
Sigma-Aldrich
二氯甲烷, puriss., meets analytical specification of Ph. Eur., NF, ≥99% (GC)